What is a peptide?

Definition and chemical architecture

Peptides are molecules built from amino acids linked in a defined order by peptide bonds. Chemically, a peptide bond is an amide linkage formed between the carboxyl group of one amino acid and the amino group of the next. The resulting chain has directionality: an amino, or N-terminus, at one end and a carboxyl, or C-terminus, at the other. This apparently simple architecture produces enormous chemical diversity because the twenty common proteinogenic amino acids differ in size, charge, polarity, aromaticity and reactivity. The sequence therefore determines far more than a name. It determines elemental composition, theoretical mass, charge state, hydrophobicity, propensity to form secondary structure, susceptibility to chemical degradation and behaviour during analytical separation.

Where peptides end and proteins begin

The distinction between a peptide and a protein is useful but not absolute. Short chains are conventionally called peptides and longer, folded chains are usually called proteins, with a rough boundary often placed near 50 amino-acid residues. There is no universal chemical rule at that number. Some biologically active peptides are longer, and some small proteins are shorter. What matters analytically is not the label but the exact sequence and chemical form. A 15-residue peptide and a 15-residue analogue containing a single substituted residue can have measurably different mass, retention time, solubility and receptor affinity.

Chemical form and composition

Peptides may be linear, cyclic, amidated, acetylated, phosphorylated, glycosylated or otherwise modified. They may also be supplied as different counter-ion or salt forms, commonly acetate or trifluoroacetate after purification. Those forms can change the total mass of material in a vial without changing the underlying peptide sequence. Residual water and solvent can contribute further mass. This is why a nominal vial weight and an HPLC purity percentage do not, by themselves, fully describe composition. A defensible material record identifies the sequence, chemical modifications, relevant salt or counter-ion form, and analytical evidence tied to the specific batch.

Sequence and identity testing

Sequence also underpins identity testing. The elemental composition of a defined sequence gives a predictable theoretical molecular mass. Mass spectrometry can then measure ions derived from the material and determine whether the observed mass is consistent with the expected peptide. For larger or multiply charged peptides, software reconstructs the neutral mass from a series of charge states. More advanced tandem mass spectrometry can fragment the peptide and compare fragment ions with the sequence, providing stronger evidence than intact mass alone.

Chromatographic behaviour

Chromatography answers a different question. Reversed-phase HPLC separates components largely according to their interaction with a hydrophobic stationary phase under a controlled solvent gradient. A peptide's side-chain chemistry influences where it elutes. The resulting chromatogram

can show whether most detected signal belongs to one major species or whether appreciable related impurities are present. Retention time may support identity when compared under controlled conditions, but it is not unique enough to prove identity on its own.

Why documentation matters

For technical work, the important principle is that the peptide name on a label is only the starting point. The scientifically meaningful identity is the sequence plus its chemical form, supported by batch-linked analytical data. Two vials carrying the same common name can differ in purity, counter-ion content, water content, residual solvent, fill amount and degradation history. Reliable interpretation therefore depends on documentation that connects the physical vial to a specific lot and to analytical results generated for that lot.